Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
63
CSTM Quote, Financials, Valuation and Earnings
Last price:
$13.69
Seasonality move
:
-3.3%
Day range:
$13.28 - $13.69
52-week range:
$7.33 - $19.53
Dividend yield:
0%
P/E ratio:
29.62x
P/S ratio:
0.27x
P/B ratio:
2.60x
Volume:
1.4M
Avg. volume:
1.6M
1-year change:
-30.72%
Market cap:
$1.9B
Revenue:
$7.3B
EPS (TTM):
$0.46
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | $7B | $8.5B | $7.8B | $7.3B | |
| Revenue Growth (YoY) | 2.01% | 15.98% | 22.49% | -8.28% | -6.27% | |
| Cost of Revenues | $5B | $6.2B | $7.6B | $6.8B | $6.4B | |
| Gross Profit | $559.6M | $751.8M | $963M | $1.1B | $938M | |
| Gross Profit Margin | 10.04% | 10.79% | 11.29% | 13.48% | 12.79% | |
| R&D Expenses | $44.5M | $44.2M | $46M | $52M | $49M | |
| Selling, General & Admin | $270.7M | $292.1M | $284M | $317M | $313M | |
| Other Inc / (Exp) | -$95.9M | $101.9M | -$89M | -$41M | -$28M | |
| Operating Expenses | $315.2M | $336.3M | $620M | $669M | $666M | |
| Operating Income | $244.4M | $415.5M | $343M | $386M | $272M | |
| Net Interest Expenses | $187.3M | $158.5M | $104M | $113M | $109M | |
| EBT. Incl. Unusual Items | -$38.8M | $358.9M | $150M | $232M | $135M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$19.4M | $62.3M | -$165M | $75M | $75M | |
| Net Income to Company | -$19.4M | $296.6M | $315M | $157M | $60M | |
| Minority Interest in Earnings | -$4.6M | -$5.7M | -$7M | -$5M | -$4M | |
| Net Income to Common Excl Extra Items | -$24M | $291M | $308M | $152M | $56M | |
| Basic EPS (Cont. Ops) | -$0.17 | $2.06 | $2.14 | $1.04 | $0.38 | |
| Diluted EPS (Cont. Ops) | -$0.17 | $1.98 | $2.14 | $1.04 | $0.38 | |
| Weighted Average Basic Share | $138.7M | $141M | $143.6M | $146.1M | $145.7M | |
| Weighted Average Diluted Share | $138.7M | $147.2M | $147M | $148.5M | $148M | |
| EBITDA | $419.1M | $802.7M | $539M | $639M | $542M | |
| EBIT | $123.3M | $500.4M | $249M | $339M | $238M | |
| Revenue (Reported) | $5.6B | $7B | $8.5B | $7.8B | $7.3B | |
| Operating Income (Reported) | $244.4M | $415.5M | $343M | $386M | $272M | |
| Operating Income (Adjusted) | $123.3M | $500.4M | $249M | $339M | $238M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $2.2B | $2.1B | $1.9B | $2B | |
| Revenue Growth (YoY) | -0.81% | 40.51% | -3.44% | -11.86% | 5.27% | |
| Cost of Revenues | $1.4B | $2B | $2B | $1.6B | $1.7B | |
| Gross Profit | $166.5M | $242.2M | $175.6M | $245M | $263M | |
| Gross Profit Margin | 10.59% | 10.97% | 8.23% | 13.03% | 13.29% | |
| R&D Expenses | $12.9M | $12.3M | $14.2M | $15M | $13M | |
| Selling, General & Admin | $70.3M | $75.9M | $77.4M | $80M | $78M | |
| Other Inc / (Exp) | -- | -- | -$16.4M | -$18M | -$4M | |
| Operating Expenses | $32.8M | -$34.6M | $91.6M | $170M | $169M | |
| Operating Income | $133.6M | $276.8M | $84M | $75M | $94M | |
| Net Interest Expenses | $64.5M | $33.5M | $38.2M | $27M | $28M | |
| EBT. Incl. Unusual Items | $69.2M | $243.3M | $29.4M | $30M | $62M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.9M | $43.5M | $5.5M | $8M | $24M | |
| Net Income to Company | $56.3M | $199.8M | $24M | $22M | $38M | |
| Minority Interest in Earnings | -$2.3M | -$2.2M | -$2.2M | -$1M | -$1M | |
| Net Income to Common Excl Extra Items | $53.9M | $197.6M | $21.8M | $21M | $37M | |
| Basic EPS (Cont. Ops) | $0.39 | $1.40 | $0.15 | $0.14 | $0.26 | |
| Diluted EPS (Cont. Ops) | $0.38 | $1.34 | $0.15 | $0.14 | $0.26 | |
| Weighted Average Basic Share | $140M | $141.7M | $144.3M | $146.8M | $142.5M | |
| Weighted Average Diluted Share | $145.9M | $147.5M | $147.3M | $150.2M | $144.1M | |
| EBITDA | $207.5M | $350.5M | $146.1M | $106M | $141M | |
| EBIT | $133.6M | $276.8M | $67.6M | $31M | $63M | |
| Revenue (Reported) | $1.6B | $2.2B | $2.1B | $1.9B | $2B | |
| Operating Income (Reported) | $133.6M | $276.8M | $84M | $75M | $94M | |
| Operating Income (Adjusted) | $133.6M | $276.8M | $67.6M | $31M | $63M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.8B | $7.7B | $8.9B | $7.7B | $7.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.3B | $6.8B | $7.9B | $6.6B | $6.3B | |
| Gross Profit | $585.9M | $835.3M | $938.5M | $1.1B | $1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $45.3M | $43.9M | $50M | $53.6M | $44.7M | |
| Selling, General & Admin | $281.5M | $300.4M | $299.2M | $324.1M | $303.9M | |
| Other Inc / (Exp) | -$21.8M | $46.4M | -$155.3M | -$44.3M | -$13M | |
| Operating Expenses | $276.4M | $322.5M | $615.6M | $752.7M | $730.6M | |
| Operating Income | $309.5M | $512.8M | $322.9M | $382.9M | $276.5M | |
| Net Interest Expenses | $212.4M | $123.4M | $115.7M | $103.9M | $98.7M | |
| EBT. Incl. Unusual Items | $75.3M | $537.7M | -$37M | $234.7M | $164.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $93.7M | -$198.1M | $78M | $89M | |
| Net Income to Company | $69.6M | $440.2M | $139.2M | $155M | $76M | |
| Minority Interest in Earnings | -$7.2M | -$5.6M | -$7.3M | -$3.9M | -$3.9M | |
| Net Income to Common Excl Extra Items | $66.1M | $438.4M | $153.7M | $152.7M | $71.9M | |
| Basic EPS (Cont. Ops) | $0.49 | $3.14 | $1.00 | $0.91 | $0.46 | |
| Diluted EPS (Cont. Ops) | $0.47 | $3.02 | $0.98 | $0.90 | $0.46 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $564.4M | $945.4M | $377.4M | $607.4M | $529.9M | |
| EBIT | $252.7M | $640.5M | $69.5M | $306.6M | $230.5M | |
| Revenue (Reported) | $5.8B | $7.7B | $8.9B | $7.7B | $7.3B | |
| Operating Income (Reported) | $309.5M | $512.8M | $322.9M | $382.9M | $276.5M | |
| Operating Income (Adjusted) | $252.7M | $640.5M | $69.5M | $306.6M | $230.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $2.2B | $2.1B | $1.9B | $2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $2B | $2B | $1.6B | $1.7B | |
| Gross Profit | $166.5M | $242.2M | $175.6M | $245M | $263M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.9M | $12.3M | $14.2M | $15M | $13M | |
| Selling, General & Admin | $70.3M | $75.9M | $77.4M | $80M | $78M | |
| Other Inc / (Exp) | -- | -- | -$16.4M | -$18M | -$4M | |
| Operating Expenses | $32.8M | -$34.6M | $91.6M | $170M | $169M | |
| Operating Income | $133.6M | $276.8M | $84M | $75M | $94M | |
| Net Interest Expenses | $64.5M | $33.5M | $38.2M | $27M | $28M | |
| EBT. Incl. Unusual Items | $69.2M | $243.3M | $29.4M | $30M | $62M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.9M | $43.5M | $5.5M | $8M | $24M | |
| Net Income to Company | $56.3M | $199.8M | $24M | $22M | $38M | |
| Minority Interest in Earnings | -$2.3M | -$2.2M | -$2.2M | -$1M | -$1M | |
| Net Income to Common Excl Extra Items | $53.9M | $197.6M | $21.8M | $21M | $37M | |
| Basic EPS (Cont. Ops) | $0.39 | $1.40 | $0.15 | $0.14 | $0.26 | |
| Diluted EPS (Cont. Ops) | $0.38 | $1.34 | $0.15 | $0.14 | $0.26 | |
| Weighted Average Basic Share | $140M | $141.7M | $144.3M | $146.8M | $142.5M | |
| Weighted Average Diluted Share | $145.9M | $147.5M | $147.3M | $150.2M | $144.1M | |
| EBITDA | $207.5M | $350.5M | $146.1M | $106M | $141M | |
| EBIT | $133.6M | $276.8M | $67.6M | $31M | $63M | |
| Revenue (Reported) | $1.6B | $2.2B | $2.1B | $1.9B | $2B | |
| Operating Income (Reported) | $133.6M | $276.8M | $84M | $75M | $94M | |
| Operating Income (Adjusted) | $133.6M | $276.8M | $67.6M | $31M | $63M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $508M | $133.6M | $152.3M | $223M | $141M | |
| Short Term Investments | $48M | $65.7M | $33.2M | $33.2M | $26M | |
| Accounts Receivable, Net | $419.4M | $682.7M | $498.7M | $418M | $381M | |
| Inventory | $715.8M | $1.2B | $1.4B | $1.2B | $1.2B | |
| Prepaid Expenses | $7.4M | $10.2M | $8.6M | $8.8M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.8B | $2.2B | $2.2B | $2B | $1.8B | |
| Property Plant And Equipment | $2.3B | $2.2B | $2.2B | $2.4B | $2.4B | |
| Long-Term Investments | $22.1M | $13.6M | $8.6M | $2.2M | -- | |
| Goodwill | $512.9M | $510.6M | $512.6M | $41M | $46M | |
| Other Intangibles | $75M | $65.7M | $57.9M | $104M | $97M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.1B | $5.2B | $5.3B | $4.9B | $4.7B | |
| Accounts Payable | $770M | $1.2B | $1.2B | $1B | $959M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $113.2M | $292.1M | $158.7M | $41M | $39M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $18M | $17M | |
| Other Current Liabilities | $56.6M | $28.3M | $54.7M | $37M | $33M | |
| Total Current Liabilities | $1.3B | $1.9B | $1.8B | $1.6B | $1.4B | |
| Long-Term Debt | $2.8B | $2.1B | $2B | $1.9B | $1.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.2B | $4.9B | $4.5B | $4.2B | $4B | |
| Common Stock | $3.7M | $3.4M | $3.2M | $4M | $4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -$14M | |
| Common Equity | -$141.4M | $310.2M | $783.9M | $718M | $706M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $17.2M | $19.2M | $22.5M | $24M | $21M | |
| Total Equity | -$124.2M | $329.5M | $806.4M | $742M | $727M | |
| Total Liabilities and Equity | $5.1B | $5.2B | $5.3B | $4.9B | $4.7B | |
| Cash and Short Terms | $555.9M | $199.3M | $185.5M | $223M | $141M | |
| Total Debt | $2.9B | $2.4B | $2.2B | $1.9B | $1.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $400.9M | $178.6M | $210.5M | $194.4M | $118M | |
| Short Term Investments | -- | $122.8M | $31.6M | $21.6M | -- | |
| Accounts Receivable, Net | $539.3M | $1B | $839.6M | $707.3M | $665M | |
| Inventory | $824.1M | $1.5B | $1.3B | $1.2B | $1.3B | |
| Prepaid Expenses | $28.1M | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.9B | $2.8B | $2.4B | $2.1B | $2.2B | |
| Property Plant And Equipment | $2.2B | $2.2B | $2.2B | $2.2B | $2.5B | |
| Long-Term Investments | -- | $17.9M | $5.5M | $1.1M | -- | |
| Goodwill | $511.1M | $513.4M | $511.4M | $509.7M | $46M | |
| Other Intangibles | $71.5M | $63.6M | $55.6M | $48.6M | $94M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.1B | $5.8B | $5.5B | $5.2B | $5.2B | |
| Accounts Payable | $963.6M | $1.9B | $1.7B | $1.5B | $1.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $96.1M | $283.5M | $238.8M | $56.2M | $35M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $19M | |
| Other Current Liabilities | $51.6M | $26.8M | $48M | $37.8M | $42M | |
| Total Current Liabilities | $1.5B | $2.3B | $2B | $1.6B | $1.8B | |
| Long-Term Debt | $2.6B | $2.1B | $2.1B | $2B | $1.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5B | $5.2B | $4.7B | $4.2B | $4.4B | |
| Common Stock | $3.5M | $3.3M | $3.3M | $3.2M | $4M | |
| Other Common Equity Adj | -- | -- | -- | $166.3M | $166M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $17.6M | $21.2M | $22.9M | $21.6M | $20M | |
| Total Equity | $7M | $610.5M | $834.2M | $982.7M | $765M | |
| Total Liabilities and Equity | $5.1B | $5.8B | $5.5B | $5.2B | $5.2B | |
| Cash and Short Terms | $400.9M | $301.4M | $242.1M | $216M | $118M | |
| Total Debt | $2.7B | $2.4B | $2.3B | $2B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$19.4M | $296.6M | $315M | $157M | $60M | |
| Depreciation & Amoritzation | $295.8M | $302.3M | $290M | $300M | $304M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $41.1M | -$257M | $73M | -$37M | -$50M | |
| Change in Inventories | $71.9M | -$492.5M | -$249M | $202M | -$24M | |
| Cash From Operations | $381.4M | $404.2M | $365M | $432M | $301M | |
| Capital Expenditures | $207.8M | $262.7M | $289M | $366M | $413M | |
| Cash Acquisitions | -- | $1.1M | -- | $51M | $3M | |
| Cash From Investing | -$201M | -$250.2M | -$196M | -$216M | -$313M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $539M | $806.1M | $76M | -- | $725M | |
| Long-Term Debt Repaid | -$278.7M | -$1.2B | -$220M | -$166M | -$697M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$79M | |
| Other Financing Activities | -$19.4M | -$65.7M | -$6M | -$11M | -$10M | |
| Cash From Financing | $115.3M | -$492.5M | -$150M | -$177M | -$61M | |
| Beginning Cash (CF) | $210.1M | $497M | $166M | $176M | $223M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $295.8M | -$338.5M | $19M | $39M | -$73M | |
| Ending Cash (CF) | $501.3M | $166.4M | $176M | $223M | $141M | |
| Levered Free Cash Flow | $173.6M | $141.5M | $76M | $66M | -$112M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $56.3M | $199.8M | $24M | $22M | $38M | |
| Depreciation & Amoritzation | $73.9M | $73.7M | $78.5M | $75M | $78M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$126.6M | -$234.4M | -$236.6M | -$173M | -$273M | |
| Change in Inventories | -$127.8M | -$285.7M | $85.1M | $16M | -$69M | |
| Cash From Operations | $87.9M | $64.7M | $37.1M | $37M | $58M | |
| Capital Expenditures | $37.5M | $36.8M | $75.2M | $74M | $69M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$34M | -$35.7M | -$74.2M | -$50M | -$59M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $485.3M | -- | -- | $1M | $5M | |
| Long-Term Debt Repaid | -$640.1M | -$15.6M | -$10.9M | -$4M | -$3M | |
| Repurchase of Common Stock | -- | -- | -- | -$7M | -$15M | |
| Other Financing Activities | -$15.2M | -- | -$2.2M | -- | -$13M | |
| Cash From Financing | -$170M | -$15.6M | $66.5M | -$10M | -$26M | |
| Beginning Cash (CF) | $514.6M | $164.1M | $181M | $223M | $141M | |
| Foreign Exchange Rate Adjustment | $2.3M | $1.1M | -$1.1M | -$6M | $4M | |
| Additions / Reductions | -$116.1M | $13.4M | $29.4M | -$23M | -$27M | |
| Ending Cash (CF) | $400.9M | $178.6M | $210.5M | $194M | $118M | |
| Levered Free Cash Flow | $50.4M | $27.9M | -$38.2M | -$37M | -$11M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $69.6M | $440.2M | $139.2M | $155M | $76M | |
| Depreciation & Amoritzation | $319.6M | $302.1M | $294.8M | $296.5M | $307M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$27.2M | -$364.8M | $70.8M | $26.6M | -$150M | |
| Change in Inventories | -$31.5M | -$650.5M | $121.8M | $132.9M | -$109M | |
| Cash From Operations | $339.9M | $381M | $337.3M | $431.9M | $322M | |
| Capital Expenditures | $198.5M | $262M | $327.4M | $364.8M | $408M | |
| Cash Acquisitions | -- | -- | -- | $51M | $3M | |
| Cash From Investing | -$187.6M | -$251.9M | -$234.4M | -$191.9M | -$322M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | -- | -- | -- | $729M | |
| Long-Term Debt Repaid | -$928M | -$602.9M | -$215.3M | -$159.1M | -$696M | |
| Repurchase of Common Stock | -- | -- | -- | -$7M | -$87M | |
| Other Financing Activities | -$40.6M | -- | -$8.2M | -- | -$23M | |
| Cash From Financing | -$44.7M | -$338.2M | -$67.9M | -$253.5M | -$77M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $107.6M | -$209.1M | $35M | -$13.4M | -$77M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $141.4M | $119M | $9.9M | $67.2M | -$86M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $56.3M | $199.8M | $24M | $22M | $38M | |
| Depreciation & Amoritzation | $73.9M | $73.7M | $78.5M | $75M | $78M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$126.6M | -$234.4M | -$236.6M | -$173M | -$273M | |
| Change in Inventories | -$127.8M | -$285.7M | $85.1M | $16M | -$69M | |
| Cash From Operations | $87.9M | $64.7M | $37.1M | $37M | $58M | |
| Capital Expenditures | $37.5M | $36.8M | $75.2M | $74M | $69M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$34M | -$35.7M | -$74.2M | -$50M | -$59M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $485.3M | -- | -- | $1M | $5M | |
| Long-Term Debt Repaid | -$640.1M | -$15.6M | -$10.9M | -$4M | -$3M | |
| Repurchase of Common Stock | -- | -- | -- | -$7M | -$15M | |
| Other Financing Activities | -$15.2M | -- | -$2.2M | -- | -$13M | |
| Cash From Financing | -$170M | -$15.6M | $66.5M | -$10M | -$26M | |
| Beginning Cash (CF) | $514.6M | $164.1M | $181M | $223M | $141M | |
| Foreign Exchange Rate Adjustment | $2.3M | $1.1M | -$1.1M | -$6M | $4M | |
| Additions / Reductions | -$116.1M | $13.4M | $29.4M | -$23M | -$27M | |
| Ending Cash (CF) | $400.9M | $178.6M | $210.5M | $194M | $118M | |
| Levered Free Cash Flow | $50.4M | $27.9M | -$38.2M | -$37M | -$11M | |
Get CSTM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CSTM
Sector
P/E ratio
29.62x
16.29x
PEG ratio
--
0.00x
P/B ratio
2.60x
1.42x
Price / LTM sales
0.27x
1.42x
Growth Metrics
CSTM
Sector
Revenue growth
5.27%
1.07%
Earnings growth
85.71%
--
Revenue (5-year growth)
6.04%
3.71%
Earnings forecast
$0.31
$0.04
Profitability
CSTM
Sector
Profitability FY 2024
$938M
--
Return on invested capital
2.48%
1.75%
Return on assets
1.4%
1.06%
Return on equity
7.91%
2.52%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
30
Balance Sheet
CSTM
Sector
Total cash
$118M
$2.4M
Short term investments
$26M
$326.7K
Total assets
$4.7B
$21.1M
Long term debt
$1.9B
$74M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
